![Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents](https://www.frontiersin.org/files/MyHome%20Article%20Library/267938/267938_Thumb_400.jpg)
Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents
![Treatments targeting putative mechanisms in irritable bowel syndrome | Nature Reviews Gastroenterology & Hepatology Treatments targeting putative mechanisms in irritable bowel syndrome | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncpgasthep0096/MediaObjects/41575_2005_Article_BFncpgasthep0096_Fig1_HTML.gif)
Treatments targeting putative mechanisms in irritable bowel syndrome | Nature Reviews Gastroenterology & Hepatology
![JCM | Free Full-Text | Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management JCM | Free Full-Text | Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management](https://www.mdpi.com/jcm/jcm-10-03429/article_deploy/html/images/jcm-10-03429-g001.png)
JCM | Free Full-Text | Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management
![Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain: Trends in Pharmacological Sciences Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain: Trends in Pharmacological Sciences](https://www.cell.com/cms/asset/a2f19f9a-b230-4212-8d51-2ea972165837/gr1.jpg)
Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain: Trends in Pharmacological Sciences
![Frontiers | Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders Frontiers | Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders](https://www.frontiersin.org/files/Articles/808195/fphar-13-808195-HTML/image_m/fphar-13-808195-g001.jpg)
Frontiers | Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
![PDF) A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline Receptors PDF) A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline Receptors](https://i1.rgstatic.net/publication/232212801_A_Second_Generation_of_Centrally_Acting_Antihypertensive_Agents_Act_on_Putative_I1-Imidazoline_Receptors/links/5b9038b745851540d1cc7ec2/largepreview.png)
PDF) A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline Receptors
![Emerging pharmacological therapies for IBS and mechanisms of action.... | Download Scientific Diagram Emerging pharmacological therapies for IBS and mechanisms of action.... | Download Scientific Diagram](https://www.researchgate.net/publication/51651885/figure/fig1/AS:339880719732738@1458045286461/Emerging-pharmacological-therapies-for-IBS-and-mechanisms-of-action-Blue-boxes-represent.png)
Emerging pharmacological therapies for IBS and mechanisms of action.... | Download Scientific Diagram
![Elucidating the putative link between prefrontal neurotransmission, functional connectivity, and affective symptoms in irritable bowel syndrome | Scientific Reports Elucidating the putative link between prefrontal neurotransmission, functional connectivity, and affective symptoms in irritable bowel syndrome | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-50024-3/MediaObjects/41598_2019_50024_Fig1_HTML.png)